Plné znění - 278/2014 Sb.

Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2015

278/2014 Sb.

Sdělení Ministerstva zdravotnictví

INFORMACE

278

XXXXXXX

Xxxxxxxxxxxx xxxxxxxxxxxxx

xx xxx 20. listopadu 2014

x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx xxxxxxxxxx, xxxxxxxx a mimořádná xxxxxxxx pro xxx 2015

Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. x) xxxxxx x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx, xx xxxxx xxxxxxxxxx xxxxxxxx, stanoví xx základě xxxxxxxxxx Xxxxxxx imunizační komise xxxxxxxxx xxxxxxx očkovacích xxxxx xxx xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx xxx 2015:

1. Xxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxxxx očkování

1a) xxxxxxxxxxx xxxxxxxx látka proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX):

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxx filamentosum

Pertussis xxxxxxxxx xxxxxxxx xxxxxxxxx

Xxxxxxxxxxx xxxxxxxxxx

Xxxxxx xxxxxxxxxx xxx.

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B xxxxxxxxxxxxxx

Xxxxx poliomyelitidis xxxxxxxxxxx xxxxx 1

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx xxxxx 3

Xxxxxxxxxx Xxx: Xxxxxxxxxxxxxxxxxxx xxxxxxxx Haemophilus xxxxxxxxxx x, Xxxxxx anatoxinum

NEBO

1aa) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x ( DTaPHibVHBIPV)

Diphtheriae xxxxxxxxxx

Xxxxxx xxxxxxxxxx

Xxxxxxxx Xxxxxxxxxx xxxxxxxxx

Xxxxxxxxx xxxxxxxxxx

Xxxxxxxxxxxxxx filamentosum

Virus Poliomyelitidis (xxxxxxxxxxxx)

xxxxx 1 (Mahoney)

typus 2 (XXX-1)

xxxxx 3 (Xxxxxxx)

Xxxxxxxxx xxxxxxxxx hepatitidy X

Xxxxxxxxxxx xxxxxxxxxx xxxx x polysaccharidum

(Polyribosylribitoli xxxxxxxx)

xxxxxxxxx xxx tetani xxxxxxxxxx

1x) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu (XXxX):

Xxxxxxxxxxx anatoxinum ≥ 30 xxxxxxxxxxxxx jednotek

Tetani xxxxxxxxxx&xxxx;≥ 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (PT) 25 xxxxxxxxxx

Xxxxxxxxx haemaglutininum xxxxxxxxxxxx (XXX) 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) 8 xxxxxxxxxx

1x) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx forma), tetanu, xxxxxxx xxxxxxxxx Hemofilem xxxxxxxxxx x (XXxXXxx):

Xxxxxxxxxxx xxxxxxxxxx ........................................... min. 30 xxxxxxxxxxxxx jednotek

Tetani xxxxxxxxxx .................................................... xxx. 40 xxxxxxxxxxxxx xxxxxxxx

Xxxxxxxxx xxxxxxxxxx (XX) ...................................... 25 xxxxxxxxxx

Xxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxxxxx (FHA) .... 25 xxxxxxxxxx

Xxxxxxxxxxx (69xX) ................................................... 8 mikrogramů

Haemophilus xxxxxxxxxx B ....................................... 10 xxxxxxxxxx

xxx anatoxino xxxxxxxx ............................................ 20-40 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxxx vyvolaným Xxxxxxxxxxx influenzae xxx x:

1 xxxxx xxxxxxxxxxxxx xxxxxxx xxxxxxxx: Xxxxxxxxxxxxxxx Xxx purificatum (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (xxxxxxxxx 25 xxxxxxxxxx).

1x) xxxxxxxx xxxxx xxxxx tetanu:

Tetani anatoxinum ................................................... xxx. 40 xxxxxxxxxxxxx jednotek

1f) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx 15 let xxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X .......................... 10 xxxxxxxxxx

1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx B xx 16 let x xxxx:

Xxxxxxxxx tegiminis xxxxxxxxxxx X ........................... 20 mikrogramů

1h) xxxxxxxx xxxxx xxxxx spalničkám, xxxxxxxxxx x zarděnkám:

Morbillorum xxxxx attenuatum (Schwarz) xxx. 10^3,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx₅₀

Xxxxxxxxxxx xxxxx xxxxxxxxxx (XXX 4385) xxx. 10^3,7 xxxxxxxx xxxxx xxx xxxxxxxx kulturu₅₀

Rubeolae xxxxx attenuatum (Xxxxxx XX 27/3) xxx. 10^3,0 infekční xxxxx xxx xxxxxxxx xxxxxxx₅₀

1xx) xxxxxxxx xxxxx proti xxxxxx přenosné xxxxx x xxxxxxxxxxxx xxxxx:

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) ........... 40 antigenních X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (MEF-1) ................ 8 antigenních X xxxxxxxx*

Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx typus 3 (Xxxxxxx) ............. 32 xxxxxxxxxxx X xxxxxxxx*

* xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx stanovené xxxxxx xxxxxx xxxxxxxxxxxxx metody.

1i) xxxxxxxx látka proti xxxxxxx xxxxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx v polysacharidové xxxxxxx:

Xxxxxxxxxxxxxxx Streptococci xxxxxxxxxx xxxxx:

1, 2, 3, 4, 5, 6X, 7X, 8, 9X, 9X, 10X, 11 X, 12X, 14, 15X, 17F, 18X, 19X, 19X, 20, 22X, 23F, 33F ...... 25 mikrogramů x xxxxxxx xxxxxxxx

1x) xxxxxxxx látka xxxxxxxxxxx xxxxx pneumokokovým xxxxxxxx:

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 1

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 3

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 4

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 5

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7F

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 9X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 14

Pneumococcale xxxxxxxxxxxxxxx xxxxxxxxx 18X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 19X

Xxxxxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 23X

1xx) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx kašli (xxxxxxxxxx forma), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma):

Diphtheriae anatoxinum ............................... ne méně xxx 2 xxxxxxxxxxx xxxxxxxx

Xxxxxx xxxxxxxxxx ........................................ xx xxxx xxx 20 mezinárodních xxxxxxxx

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxxx................................... 8 xxxxxxxxxx

Xxxxxxxxx haemagglutinum filamentosum ... 8 mikrogramů

Pertaktin ...................................................... 2,5 xxxxxxxxxx

Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:

xxxxx 1 (xxxx Xxxxxxx) .............................. 40 X jednotek xxxxxxxx

xxxxx 2 (xxxx XXX-1) ................................... 8 X xxxxxxxx xxxxxxxx

xxxxx 3 (xxxx Xxxxxxx) ................................ 32 X xxxxxxxx xxxxxxxx

XXXX

1xx) očkovací xxxxx proti xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):

Xxxxxxxxxx toxoid ....................................... xxxx xxxx rovno 2 xxxxxxxxxxx jednotky (2 Xx)

Xxxxxxxxx xxxxxx ....................................... xxxx xxxx xxxxx 20 xxxxxxxxxxxxx xxxxxxxx (5 Xx)

Xxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxx ................................ 2,5 xxxxxxxxxx

Xxxxxxxxxxxx hemaglutinin ................. 5 xxxxxxxxxx

Xxxxxxx xxxx 2+3 ................................ 5 xxxxxxxxxx

Xxxxxxxxx ............................................. 3 mikrogramy

Virus xxxxxxxxxxxxx xxxx 1 (xxxxxxxxxxxx) ... 40 xxxxxxxxxxx X jednotek

Virus poliomyelitis xxxx 2 (inaktivovaný) ... 8 xxxxxxxxxxx X jednotek

Virus xxxxxxxxxxxxx xxxx 3 (xxxxxxxxxxxx) ... 32 xxxxxxxxxxx X xxxxxxxx

1x) očkovací xxxxx xxxxx xxxxxxxxxxx:

Xxxxxxxxxxxxx xxxxx xxxxxxxxxx (XXX) xxxxxxx Danisuc 1331 ... 0,75 xx&xxxx;≥ 2,0 x 10⁶ ≤ 8,0 x 10⁶ XXX (xxxxxx xxxxxxx)

1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:

Xxxxxxxxx xxxxxxxxx hepatitidis X biosyntheticum 20 xxxxxxxxxx; xxxxxxxx XX04X xxxxxxxxxx 3-X-xxxxxx-4-xxxxxxxxxxxx-xxxxx A (XXX) 50 xxxxxxxxxx x 1 xxxxx

2. Xxxxxxxxx složení očkovacích xxxxx pro xxxxxxxx xxxxxxxx

2x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:

Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X 20 xxxxxxxxxx

2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx

Xxxxx rabiei xxxxxxxxxxx (kmen Wistar xxxxxx XX/XX 38 1503-3M xxxx xxxx rovno 2,5 xxxxxxxxxxxxx xxxxxxxx x 1 dávce (0,5 xx)

2x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xx xxxxxxx pro xxxxxxx:

Xxxxxxxxx X xxxxx inactivatum

3. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx mimořádná xxxxxxxx

3x) očkovací xxxxx xxxxx xxxxxx xxxxxxxxxx X xx xxxxxxx xxx dospělé:

Hepatitis A xxxxx xxxxxxxxxxx

3x) očkovací xxxxx proti xxxxxx xxxxxxxxxx X xx xxxxxxx xxx xxxx:

Xxxxx xxxxxxxxx X inactivatum

V xxxx 2015 x xxxxxxx na plánovanou xxxxxxxxxx xxxxxxxx č. 537/2006 Sb., x xxxxxxxx proti xxxxxxxxx xxxxxxx, xxxxx xxxxxxxx případnou xxxxxx xxxxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxxxx xxxxxxxx publikováním xxxxxx xxxxxxxxxxx xxxxxxx těchto xxxxxxxxxx látek ve Xxxxxx xxxxxx.

Xxxxxxx:

XXXx. Xxxxxxx, XXX, x. x.

Informace

Právní xxxxxxx x. 278/2014 Sb. xxxxx xxxxxxxxx dnem 13.12.2014.

Xx xxx uzávěrky právní xxxxxxx xxxxx měněn xx xxxxxxxxx.

Xxxxx xxxxxxxxxxxx xxxxxxxx norem xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx se jich xxxxxx xxxxxxxxx změna xxxxx xxxxxxxxx právního xxxxxxxx.